Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study (Q28219349)

object named as

Margaret R Karagas

0 references

author name string

Joan Fortuny

0 references

Michael S Zens

0 references

Alan Schned

0 references

Angeline S Andrew

0 references

John Heaney

Use of analgesics and nonsteroidal anti-inflammatory drugs, genetic predisposition, and bladder cancer risk in Spain

0 references

language of work or name

English

0 references

publication date

10 August 2007

0 references

0 references

0 references

0 references

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2018698

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2018698

Aspirin use and mortality from cancer in a prospective cohort study

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2018698

Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2018698

Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2018698

Cancer risk in persons receiving prescriptions for paracetamol: a Danish cohort study

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2018698

Regular use of analgesics is a risk factor for renal cell carcinoma

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2018698

Aspirin use and chronic diseases: a cohort study of the elderly

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2018698

Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2018698

Overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2018698

COX-2: a molecular target for colorectal cancer prevention

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2018698

A population-based study of immunohistochemical detection of p53 alteration in bladder cancer.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2018698

Acetaminophen down-regulates interleukin-1beta-induced nuclear factor-kappaB nuclear translocation in a human astrocytic cell line

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2018698

Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2018698

Non-steroidal anti-inflammatory drugs and bladder cancer prevention

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2018698

Aspirin use and risk of fatal cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2018698

Tumours of the renal pelvis and ureter. Observations in 170 patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2018698

Urothelial cancer at different tumour sites: role of smoking and habitual intake of analgesics and laxatives. Results of the Berlin Urothelial Cancer Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2018698

Acetaminophen and renal and bladder cancer

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2018698

Different roles for phenacetin and paracetamol in cancer of the kidney and renal pelvis

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2018698

Heavy phenacetin use and bladder cancer in women aged 20 to 49 years

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2018698

Acetaminophen and the risk of renal and bladder cancer in the general practice research database

2 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-7-13

Risk factors for renal cell carcinoma: results of a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-7-13

International renal-cell cancer study. II. Analgesics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-7-13

Genomics and proteomics analysis of acetaminophen toxicity in mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-7-13

Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2490-7-13

Cyclophosphamide is contraindicated in patients with a history of transitional cell carcinoma

21 January 2018

1 reference

12 December 2020

Expression of NF-kappa B in human bladder cancer and its clinical significance

1 reference

12 December 2020

Phenacetin abuse related to bladder cancer

1 reference

12 December 2020

Phenacetin-containing analgesics and cancer of the bladder or renal pelvis in women

1 reference

12 December 2020

Does Paracetamol Cause Urothelial Cancer or Renal Papillary Necrosis?

1 reference

12 December 2020

Aspirin use and lung, colon, and breast cancer incidence in a prospective study

1 reference

12 December 2020

Recall accuracy for prescription medications: self-report compared with database information

1 reference

12 December 2020

Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder

1 reference

12 December 2020

Transitional cell cancer of the urinary tract and renal cell cancer in relation to acetaminophen use (United States)

1 reference

12 December 2020

High-throughput tissue microarray analysis of COX2 expression in urinary bladder cancer

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2490-7-13

1 reference

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1471-2490-7-13

1 reference

1 reference

PubMed publication ID

17692123

1 reference